The reality is none of us have any idea of who specifically EAS are targeting & currently speaking to or what level of support being asked/offered.
I would expect months personally.
Using the ducks lining up train of thought. Ann's for 6 x trials & still one to come on psychedelics. Maybe looking for financial backing to take these trials through to the next stage? Also support for the US listing with the $ for that to happen.
Its been said plenty of times before but we have a very astute board that know the process well.
Peter Widdows alone is an exceptionally talented player in this field.
Personally I feel very confident of where we are & where we're heading.
I think quite a few of us see the pieces to the IHL picture just a matter of time on the catalyst Ann's?
- Forums
- ASX - By Stock
- IHL
- Ann: IHL-675A outperforms existing treatment for arthritis
Ann: IHL-675A outperforms existing treatment for arthritis, page-124
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)